ESMO 2024 Insights: Clinical and Molecular Predictors of Outcome in Patients With Tubo-Ovarian High-Grade Serous Carcinoma and Exceptional Survival

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Find latest Ovarian Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Clinical and Molecular Predictors of Outcome in Patients With Tubo-Ovarian High-Grade Serous Carcinoma and Exceptional Survival

By 2024 ESMO Annual Meeting Insights Hub FEATURING Tibor A. Zwimpfer

74 views

September 25, 2024

Comments 0

2024 ESMO Annual Meeting Insights Hub: GYN Videos

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New…

2024 ESMO Annual Meeting Insights Hub

S. Banerjee

121 views

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

447 views

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

234 views

View All

Oncology Clinical Updates - Review and Renew

Sat, Apr 5, 2025

Year in Review 2024 - Ovarian Cancer

Oncology 2024 Year in Review

E. Crane

835 views

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

2.2K views

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.9K views

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

2024 ESMO Annual Meeting Insights Hub

B. Monk

726 views

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

UCLA Health

D. Chase

387 views

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

406 views

SOCCER-P Trial: Secondary Cytoreductive Surgery in Relapsed Ovarian …

Hyun-Woong Cho

265 views

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.2K views

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

1.1K views

OVATION 2 Trial: IMNN-001 Immunotherapy + Chemo for Advanced Ovarian…

Premal Thaker

174 views

New

Comprehensive Review of PARP Inhibitors in Ovarian Cancer: Role of O…

Alexander Olawaiye

127 views

ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagn…

2024 ESMO Annual Meeting Insights Hub

B. Monk

337 views

Impact of Frontline PARP Inhibitor Approvals on Treatment Decisions …

Erin Crane

155 views

Genetic Testing in Determining Maintenance Treatment Options in Adva…

Alexander Olawaiye

184 views

Next-Generation Immunotherapy for Ovarian Cancer

Ovarian Cancer Midwest Focus, University of Minnesota

S. Powell

127 views

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

2024 ASCO® Annual Meeting Insights Hub

A. Karam

459 views

Addressing the Critical Gaps in Relapsed Ovarian Cancer Management

Michael Birrer

158 views

ESMO 2024 Insights: PRIMA Trial - Newly Diagnosed Advanced Ovarian C…

ecancer

A. González-Martín

175 views

ESMO 2024 Insights: Mirvetuximab Soravtansine-gynx (MIRV) in Platinu…

2024 ESMO Annual Meeting Insights Hub

A. Secord

149 views

Treatment Updates in Cervical & Ovarian Cancer

University of Illinois Cancer Center

J. Ray

123 views

AUTOPLAY

Login

Login

Join VuMedi

ESMO 2024 Insights: Clinical and Molecular Predictors of Outcome in Patients With Tubo-Ovarian High-Grade Serous Carcinoma and Exceptional Survival

2024 ESMO Annual Meeting Insights Hub: GYN Videos

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New…

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

Related Videos

Oncology Clinical Updates - Review and Renew

Year in Review 2024 - Ovarian Cancer

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

SOCCER-P Trial: Secondary Cytoreductive Surgery in Relapsed Ovarian …

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

OVATION 2 Trial: IMNN-001 Immunotherapy + Chemo for Advanced Ovarian…

Comprehensive Review of PARP Inhibitors in Ovarian Cancer: Role of O…

ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagn…

Impact of Frontline PARP Inhibitor Approvals on Treatment Decisions …

Genetic Testing in Determining Maintenance Treatment Options in Adva…

Next-Generation Immunotherapy for Ovarian Cancer

ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced Endomet…

Addressing the Critical Gaps in Relapsed Ovarian Cancer Management

ESMO 2024 Insights: PRIMA Trial - Newly Diagnosed Advanced Ovarian C…

ESMO 2024 Insights: Mirvetuximab Soravtansine-gynx (MIRV) in Platinu…

Treatment Updates in Cervical & Ovarian Cancer